Forecast to Publish a Funding Opportunity Announcement for Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
ID: 359892Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/359892
Timeline
    Description

    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at soliciting applications for the early-stage development of informatics technologies that enhance cancer research and management. This initiative, part of the National Cancer Institute's Informatics Technology for Cancer Research (ITCR) Program, seeks to support the creation and significant modification of tools that facilitate data acquisition, management, analysis, and dissemination across various cancer research domains, including biology, treatment, early detection, and health disparities. Interested small businesses are encouraged to develop innovative, user-friendly technologies that demonstrate potential impact on cancer research, with applications expected to be submitted after the NOFO is officially released. For further inquiries, potential applicants can contact Dr. Juli Klemm at juli.klemm@nih.gov or by phone at 202-853-7889, with the estimated synopsis post date set for August 29, 2025, and the anticipated award date in July 2026.

    Point(s) of Contact
    Juli Klemm, PhD National Cancer Institute
    (202) 853-7889
    juli.klemm@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Forecast to Publish a Funding Opportunity Announcement for Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at advancing the development of informatics technologies for cancer research and management. This initiative seeks applications for the enhancement of emerging informatics technologies that have shown potential in improving data acquisition, analysis, visualization, and interpretation across various aspects of cancer research, including biology, treatment, early detection, and health disparities. The emphasis is on technologies that are unique and have the potential for significant impact, with a requirement for clear development plans, user engagement, and collaboration strategies. While applications are not currently being solicited, interested parties are encouraged to prepare for submission, with the estimated synopsis post date set for August 29, 2025, and a projected award date of July 1, 2026. For further inquiries, potential applicants can contact Juli Klemm, PhD, at juli.klemm@nih.gov or by phone at 202-853-7889.
    Forecast to Publish a Funding Opportunity Announcement for Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at supporting the sustained development of informatics technologies for cancer research and management. This initiative seeks applications for the continued operation and enhancement of existing informatics resources that facilitate data acquisition, management, analysis, and dissemination across various aspects of cancer research, including biology, treatment, early detection, and health disparities. The emphasis is on maintaining resources that have demonstrated significant impact on cancer research, with a focus on user engagement and support. While applications are not currently being solicited, potential applicants are encouraged to prepare collaborative projects in anticipation of the NOFO, which is expected to be posted on August 29, 2025, with a closing date for submissions on November 21, 2025. For further inquiries, interested parties can contact Dr. Juli Klemm at juli.klemm@gmail.com or by phone at 202-853-7889.
    Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for Small Business Innovation Research (SBIR) Phase IIB Bridge Awards aimed at accelerating the development of cancer-relevant technologies toward commercialization. This funding opportunity is designed for small business concerns (SBCs) that have previously received SBIR or STTR Phase II awards from any Federal agency and are seeking additional funding to transition their projects to the commercialization stage. The initiative emphasizes the importance of fostering partnerships between awardees and third-party investors to support the capital-intensive steps necessary for bringing new products and services to market. While applications are not currently being solicited, the NOFO is expected to be published in Summer 2025, with an anticipated application due date in Fall 2025. For further inquiries, interested parties can contact Jonathan Franca-Koh, Ph.D., M.B.A. at 240-618-0984 or via email at francakohjc@mail.nih.gov.
    Forecast to Publish a Notice of Funding Opportunity (NOFO) for NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP) Research Bases, which requires clinical trials. This initiative aims to enhance the generalizability and dissemination of clinical trial results by engaging diverse cancer patient populations and organizations in rigorous studies focused on cancer control, prevention, treatment, and care delivery. The program anticipates awarding approximately $73 million across 50 grants, with applications from small businesses eligible, provided they are not affiliated with certain NCI-funded institutions. Interested applicants can reach out to Dr. Brandy Heckman-Stoddard at 240-276-7048 or via email at heckmanbm@mail.nih.gov for further information. The estimated synopsis will be posted on August 29, 2025, with a closing date for applications on November 14, 2025, and awards expected to be made by August 1, 2026.
    Forecast to Publish a Notice of Funding Opportunity (NOFO) for NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the NCI Community Oncology Research Program (NCORP) Research Bases, which requires clinical trials. This initiative aims to enhance the generalizability and dissemination of clinical trial results by engaging cancer patient populations and organizations in rigorous studies focused on cancer control, prevention, treatment, and care delivery. The program will support seven awards with an estimated total funding of $60 million, and applications are open to small businesses. Interested applicants should note that the synopsis is expected to be posted on August 29, 2025, with a closing date for applications on November 14, 2025, and the anticipated award date is August 1, 2026. For further inquiries, contact Brandy Heckman-Stoddard, Ph.D., M.P.H., at 240-276-7048 or via email at heckmanbm@mail.nih.gov.
    Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)." This funding aims to support innovative projects that develop technologies for analyzing and managing biospecimens in cancer research and clinical care, with a focus on proof-of-concept studies that demonstrate feasibility in areas such as cancer biology, early detection, and health disparities. The total estimated program funding is $4.7 million, with individual awards ranging from $50,000 to $150,000, and approximately 17 awards are expected to be made. Interested applicants can reach out to Dr. Kelly Crotty at Kelly.crotty@nih.gov or by phone at 240-255-0917 for further information, with applications due by April 10, 2026.
    Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the Advancing Bioinformatics, Translational Bioinformatics, and Computational Biology Research initiative, which aims to support innovative research in these fields. This initiative seeks to develop advanced methods and tools that leverage transformative technologies, such as artificial intelligence and machine learning, to enhance the interpretation of complex biological datasets, ultimately improving health outcomes. With an estimated total program funding of $2.5 million and the expectation of awarding approximately 10 grants, interested small businesses are encouraged to prepare their applications, with the anticipated synopsis posting date on October 6, 2025, and a closing date for applications on February 4, 2026. For further inquiries, potential applicants can contact Dr. Catherine Farrell at catherine.farrell@nih.gov or by phone at 301-402-7081.
    Forecast to Publish a Funding Opportunity Announcement for the Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Cancer Intervention and Surveillance Modeling Network (CISNET) under the U01 cooperative agreement mechanism, which will not allow clinical trials. This initiative aims to leverage simulation modeling to enhance the evidence derived from clinical trials, epidemiologic studies, and surveillance data, thereby informing public health research and priorities throughout the cancer continuum. The opportunity is particularly relevant for small businesses with expertise in comparative simulation modeling methods for cancer control, as well as collaborative teams that integrate knowledge from decision modeling, statistics, health economics, epidemiology, computer science, medicine, and public health. Interested applicants should prepare for the application process, with the estimated synopsis posting date set for July 31, 2025, and the application deadline anticipated for November 7, 2025. For further inquiries, potential applicants can contact Dr. Natasha Stout at natasha.stout@nih.gov or by phone at 240-478-8909.
    Forecast to Publish a Funding Opportunity Announcement for Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity for research in cancer epidemiology cohort studies through a Cooperative Agreement. This initiative aims to support hypothesis-based research that addresses critical knowledge gaps in cancer etiology and survivorship, including the maintenance of cohorts, continued follow-up, and the sharing of data and biospecimen resources. This funding is vital for advancing understanding in the field of cancer research, which can lead to improved outcomes for patients. Interested small businesses can reach out to Dr. Somdat Mahabir at mahabir@mail.nih.gov or call 240-276-6914 for more information. The estimated synopsis post date is August 1, 2025, with applications due by November 5, 2025, and awards expected to be made by July 1, 2026.
    Notice of Intent to Publish a Funding Opportunity Announcement for NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity for the NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers, designated as a UG1 Clinical Trial Not Allowed cooperative agreement. This initiative aims to support leadership and expertise in integrating translational science into clinical trials, particularly focusing on multi-center, late-phase treatment trials across various cancer types and patient demographics. The total estimated program funding is $2 million, with an award ceiling of $850,000 and an expected two awards to be made. The Notice of Funding Opportunity (NOFO) is anticipated to be published in Fall 2024, with applications due in late February 2025, and awards expected to be announced by March 1, 2026. Interested applicants should prepare their proposals accordingly.